![](https://endpts.com/wp-content/uploads/2022/06/Shehnaaz-Suliman-ReCode-tile.jpg)
Shehnaaz Suliman, ReCode Therapeutics CEO (Photo by Jennifer Leahy)
Pfizer, Sanofi-backed LNP outfit goes back to the well and draws $120M for its trek to the clinic
A preclinical biotech touting a five-lipid drug delivery platform is looking to break out of its preclinical mold, and it just secured a sizable raise …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.